- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-261/17: Judgment of the General Court of 24 October 2018 — Bayer v EUIPO — UNI-Pharma (SALOSPIR) (EU trade mark — Opposition proceedings — Application for EU figurative mark SALOSPIR — Earlier EU figurative marks representing coloured stripes and earlier national marks Aspirin — Relative grounds for refusal — Similarity of the signs — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) — Reputation — Article 8(5) of Regulation No 207/2009 (now Article 8(5) of Regulation 2017/1001) — Use of a sign of more than mere local significance in the course of trade — Article 8(4) of Regulation No 207/2009 (now Article 8(4) of Regulation 2017/1001))
ECLI:EU:UNKNOWN:62017TA0261
62017TA0261
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 445/17
(Case T-261/17) (*)
((EU trade mark - Opposition proceedings - Application for EU figurative mark SALOSPIR - Earlier EU figurative marks representing coloured stripes and earlier national marks Aspirin - Relative grounds for refusal - Similarity of the signs - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) - Reputation - Article 8(5) of Regulation No 207/2009 (now Article 8(5) of Regulation 2017/1001) - Use of a sign of more than mere local significance in the course of trade - Article 8(4) of Regulation No 207/2009 (now Article 8(4) of Regulation 2017/1001)))
(2018/C 445/22)
Language of the case: English
Parties
Applicant: Bayer AG (Leverkusen, Germany) (represented by: V. von Bomhard and J. Fuhrmann, lawyers)
Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral, S. Pétrequin and D. Walicka, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Uni-Pharma Kleon Tsetis, Farmakeutika Ergastiria AVEE (Kifisia, Greece) (represented by: C. Chrysanthis, P.-V. Chardalia and A. Vasilogamvrou, lawyers)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 17 February 2017 (Case R 2444/2017-4), relating to opposition proceedings between Bayer and Uni-Pharma Kleon Tsetis, Farmakeutika Ergastiria.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Bayer AG to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Uni-Pharma Kleon Tsetis, Farmakeutika Ergastiria AVEE in the proceedings before the General Court.
(*) Language of the case: English.
(1) OJ C 221, 10.7.2017.
* * *
(2018/C 445/22)